Intravenous immunoglobulin (IVIG) administration faces challenges due to complement activation by aggregated IgG, causing adverse reactions. Current methods to prevent these reactions show limited success, necessitating further research for safer IVIG therapies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: